within Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M09A_OtherDrugsForDisordersOfTheMusculoSkeletalSystem.M09AX10_Risdiplam;

model Risdiplam
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C_enteral(
    weight = 70,
    F = 0.55,
    Cl = 5.749999999999999e-07,
    adminDuration = 600,
    adminMass = 5 / 1000000,
    adminCount = 1,
    Vd = 0.137,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.0013333333333333333,
    Tlag = 600,
    Vdp = 0.168,
    k12 = 2.4444444444444447e-06,
    k21 = 2.4444444444444447e-06);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Risdiplam</td></tr><tr><td>ATC code:</td><td>M09AX10</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>5</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>137</td><td>L</td></tr>
    <tr><td>clearance:</td><td>2.07</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Risdiplam is an orally administered small molecule used for the treatment of spinal muscular atrophy (SMA). It acts as a survival motor neuron 2 (SMN2) splicing modifier, increasing production of functional SMN protein. Risdiplam is currently approved by the FDA and EMA for use in both pediatric and adult patients with SMA.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers and SMA patients, after oral administration.</p><h4>References</h4><ol><li><p>Cleary, Y, et al., &amp; Gertz, M (2023). Estimation of FMO3 Ontogeny by Mechanistic Population Pharmacokinetic Modelling of Risdiplam and Its Impact on Drug-Drug Interactions in Children. <i>Clinical pharmacokinetics</i> 62(6) 891–904. DOI:<a href=\"https://doi.org/10.1007/s40262-023-01241-7\">10.1007/s40262-023-01241-7</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37148485/\">https://pubmed.ncbi.nlm.nih.gov/37148485</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.M.M09AX10 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Risdiplam;
